openPR Logo
Press release

Biopharmaceutical and Biomedicine Market Insights, and Forecast to 2025

08-30-2018 03:08 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Biopharmaceutical and Biomedicine Market Insights,

Biopharmaceuticals has emerged as one of the key segments with immense growth potential in the healthcare sector. Rising demand for effective treatment and rise in per capita healthcare expenditure has led to double digit revenue growth for industry players in the recent past. The industry offers lucrative growth opportunities, since most of these products still have low penetration rate. The market is expected to gain further traction, with evolving treatment archetypes and rapid technological innovation such as cell therapy and regenerative medicines.

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/18

Launches and approvals of novel biopharmaceutical and biomedicine products is expected to drastically drive growth of global biopharmaceutical and biomedicine market in the near future. For instance, in 2016, Sanofi S.A. received U.S. FDA approval for its Adlyxin ((lixisenatide) injection. Adlyxin is indicated to improve blood sugar levels among adults suffering from type 2 diabetes. In 2016, Johnson & Johnson received U.S. FDA approval for its Stelara (Ustekinumab), indicated for the treatment of adults suffering from moderately to severely active crohn’s disease. In 2016, CSL Behring received U.S. FDA approval for its IDELVION, Coagulation Factor IX (Recombinant), Albumin Fusion Protein. IDELVION is indicated for the treatment of Hemophilia B among children and adults. In 2017, Nanostring Technologies, Inc. launched nCounter platform advances as well as new panels expanding the company’s presence in immuno-oncology and 3D biology research. In 2015, Celltrion Healthcare Co., Ltd. launched its Remsima (infliximab), a biosimilar monoclonal antibody (mAb) in Austria, Belgium, Denmark, France, Germany, Greece, Italy, Luxembourg, the Netherlands, Spain, Sweden, and the UK.

Furthermore, increasing collaborations and acquisitions by major key players in market is also expected to create lucrative environment for growth of market. For instance, in 2016, Biocon Ltd., wholly owned subsidiary of Biocon SA, collaborated with Laboratorios PiSA S.A. de C.V—a Mexico-based company—for the co-development and commercialization of generic recombinant human insulin (rh-insulin) in the U.S. market. In 2016, AbbVie Inc. acquired all rights from Boehringer Ingelheim (BI) for Risankizumab (BI 655066). Risankizumab is an anti-IL-23 monoclonal biologic antibody for psoriasis. Company is also evaluating the product for other indications such as Crohn’s disease, asthma, and psoriatic arthritis. Currently, it is in clinical phase 3.

Increasing strategic acquisitions and collaboration by key players is expected to drive market growth in the near future

Players in the market are focusing on strategic collaborations, in order to increase their product offerings. In February 2018, LGC Limited— U.K.-based Company acquired Lucigen Corporation, a U.S.-based developer, and manufacturer of molecular biology enzymes, reagents and kits. Through this strategic acquisition, LGC Limited expanded its portfolio with the Lucigen’s extensive portfolio of NGS kits, enzymes, competent cells, and cloning systems. In February 2018, Servier Laboratories and ImmunoQure AG entered into a strategic collaboration for development of a therapeutic autoantibody neutralizing interferon- a. In March 2018, Wuxi Biologics Co. Ltd. collaborated with Adagene Inc., for the discovery and development of novel antibody therapeutics. In 2017, Omicia, Inc., acquired a bioinformatics startup Spiral Genetics at an undisclosed amount. Through this acquisition of Spiral’s advanced tools, Omicia, Inc., expanded its bioinformatics tools portfolio and strengthened its position in the global market.

Moreover, increasing funding and investments to support the development and research of new biopharmaceutical is also expected to drive the market growth. For instance in 2017, Indian government launched a National Biopharmaceutical Mission. As per the program, the government has invested US $250 Mn that includes a US$ 125 Mn loan from the World Bank to promote development of biological drugs in India. In 2017, The University of Liverpool and the Johns Hopkins University School of Medicine (JHUSM) collaborated for the development of new nanomedicine approaches for HIV therapy, and received an award of US$ 3 million from National Institutes of Health (NIH) to generate new technologies and continue research and development.

Cost of biopharmaceutical and biomedicine products are quite high as these need research and development process, and its manufacturing is very complex process, which needs highly skilled scientists. Such expensive biopharmaceutical products are not affordable to organizations in emerging economies such as India, China, and Africa. High cost of biopharmaceutical and biomedicine is a major factor hindering its adoption. For instance, in India a vial of Avastin, a monoclonal antibody, costs between US$ 372.65 to US$ 402.46. High cost medicine is not affordable to everyone, hence, it is a major restraining factor for the market growth. Cost of gene therapy such as Kymriah is very high. Kymriah is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia. The cost of Novartis AG’s cancer therapy Kymriah is about US$ 475,000.

Ask for customization @ https://www.coherentmarketinsights.com/insight/request-customization/18

Key players operating in the global biopharmaceutical and biomedicine market include Amgen Inc., F. Hoffmann-La Roche AG, Novartis AG, Johnson & Johnson, Pfizer, Inc., Sanofi S.A., Eli Lilly and Company, AbbVie Inc., Novo Nordisk A/S, Bristol - Myers Squibb, NanoString Technologies, Inc., Qiagen N.V., Celgene Corporation, and Affimed N.V.

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biopharmaceutical and Biomedicine Market Insights, and Forecast to 2025 here

News-ID: 1212626 • Views: 284

More Releases from Coherent Market Insights

Organic Tobacco Market Analysis by Size, Share, Growth, Trends up to 2027
Organic Tobacco Market Industry Overview by Coherent Market Insights "Final Report Will Add the analysis of the impact of COVID-19 on this Industry." Global “Organic Tobacco Market” Research Report 2020-2027 is a historical overview and in-depth study on the current & future market of the Organic Tobacco industry. The report represents a basic overview of the Organic Tobacco market size, status, competitor segment with a basic introduction of key vendors, top regions,
Flour Market Opportunities, Share Analysis
Flour Market Industry Overview by Coherent Market Insights "Final Report Will Add the analysis of the impact of COVID-19 on this Industry." Global “Flour Market” Research Report 2020-2027 is a historical overview and in-depth study on the current & future market of the Flour industry. The report represents a basic overview of the Flour market size, status, competitor segment with a basic introduction of key vendors, top regions, product types and end
Sex Toys Market to Witness Huge Growth by 2027
Sex Toys Market Industry Overview by Coherent Market Insights "Final Report Will Add the analysis of the impact of COVID-19 on this Industry." Global “Sex Toys Market” Research Report 2020-2027 is a historical overview and in-depth study on the current & future market of the Sex Toys industry. The report represents a basic overview of the Sex Toys market size, status, competitor segment with a basic introduction of key vendors, top regions,
Video Telemedicine Market to See Huge Growth by 2027 | Huawei, Polycom, Vidyo, A …
The report offers a systematic presentation of the existing trends, growth opportunities, market dynamics that are expected to shape the growth of Global Video Telemedicine Market. The various research methods and tools were involved in the market analysis, to uncover crucial information about the market such as current & future trends, opportunities, business strategies and more, which in turn will aid the business decision-makers to make the right decision in

All 5 Releases


More Releases for Biopharmaceutical

Biopharmaceutical Drug Delivery Technologies Market Size, Share, Development by …
New report published by Global Info Research which offers insights on the Global Biopharmaceutical Drug Delivery Technologies market. Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-biopharmaceutical-drug-delivery-technologies-market_p103529.html Global Biopharmaceutical Drug Delivery Technologies Market: Forecast by Type / Application / Region This report studies the Biopharmaceutical Drug Delivery Technologies market status and
Biopharmaceutical Contract Manufacturing (BCMO) Market 2018 – 2024 | PBIGP
A Study On Biopharmaceutical Contract Manufacturing (BCMO) Market: Biopharmaceutical products are pharmaceutical drugs that are synthesized, processed, or extracted from biological sources. Biopharmaceuticals include vaccines, blood products, recombinant therapeutic proteins, allergens, gene therapies, tissues and living cells used in cell therapy. Due to lack of manufacturing capabilities and to reduce the cost of manufacturing process, many companies are outsourcing. Contract manufacturing organizations offer a wide range of services such as
Influx of Technologically Advanced Biopharmaceutical and Biomedicine Drives the …
Biopharmaceuticals has emerged as one of the key segments with immense growth potential in the healthcare sector. Rising demand for effective treatment and rise in per capita healthcare expenditure has led to double digit revenue growth for industry players in the recent past. The industry offers lucrative growth opportunities, since most of these products still have low penetration rate. The market is expected to gain further traction, with evolving treatment
Global Biopharmaceutical Contract Manufacturing Market 2025
Press Release - 16 July 2018 Research and Development News -- . . Latest Update "Global Biopharmaceutical Contract Manufacturing Market Size,Status and Forecast 2025" with Industries Survey | Global Current Growth and Future. ' ' This report studies the global Biopharmaceutical Contract Manufacturing market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Biopharmaceutical Contract Manufacturing market by companies, region, type and end-use industry. A contract manufacturer ("CM")
Biopharmaceutical Logistics Market: Future market projections for forthcoming ye …
The biopharmaceutical logistics market features a fairly competitive landscape characterized by moderate-to-high degree of competition among the players, observes Transparency Market Research (TMR). The competition in the market landscape is likely to remain unchanged over the forecast period from 2016 to 2024. However, the intensity of competition may subside to an extent, owing to prominent players exploring innovative logistics services pertaining to specific regions, The leading five companies held a
Worldwide Biopharmaceutical Logistics Industry 2017, Trends and Forecast Report
"Global Biopharmaceutical Logistics Industry 2017, Trends and Forecast Report" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- Biopharmaceutical Logistics Report by Material, Application, and Geography Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South